EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseOpen Access · CC BY 4.0

Network meta-analysis of treatments for perineal extramammary paget’s disease: Focusing on performance of recurrence prevention

Xiaobin Yuan iD, Ruizhi Xue, Xiaoming Cao iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0294152 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift PLOS ONE, 2023. Verfasst von Xiaobin Yuan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Paget Disease, Extramammary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Shanxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Perineal extramammary paget’s disease (EMPD) is characterized with high recurrence rate. Although numerous therapeutic measures for this disease have been reported so far, it is unknown whether there is significant difference in their recurrence-preventing efficiency. This study aims to compare the recurrence outcomes of reported perineal EMPD treatments.

Methods

We searched public databases of for published studies concerning perineal EMPD treatments. After screening by inclusion and exclusion criteria, we extracted the data relevant to recurrence rate, and conducted network meta-analysis (NMA) by using Bayesian random-effects approach.

Results

Our analysis included 29 previous studies (involving both male and female patients) and 11 treatment designs which are wide local excision (WLE), local excision (LE), Mohs micrographic surgery (MMS), radiotherapy (RT), radical vulvectomy (RV), photodynamic therapy (PDT), lasers (LS), imiquimod, and WLE+RT, WLE+PDT, WLE+LS. Comparing with WLE, the MMS showed significant advantage in reducing recurrence [OR: 0.18 (0.03–0.87)], while none of the rest treatments has statistically significant results. After removing outlier studies, MMS still has the significant advantages [OR: 0.35 (0.11–0.82)], and LE turned to be the treatment with worst performance [OR: 13 (2.50–110)]. Covariance analysis of follow-up length, gender differences, and lesion locations indicated only short follow-up time could affect the recurrence statistics, which tend to conceal the real differences. Funnel plot demonstrated there is no significant small study effect.

Conclusion

MMS has the best performance on reducing perineal EMPD recurrence, while LE exhibits the worst capability in such regard. Recurrence-preventing abilities of other treatments have no significant difference between each other.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paget Disease, ExtramammaryHumansMaleFemaleBayes TheoremMohs SurgeryImiquimodNeoplasm Recurrence, LocalRetrospective Studies

Substanzen

Imiquimod

Autor:innen und Institutionen

  • Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
  • First College of Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.

ORCID-Profile: Xiaobin Yuan, Xiaoming Cao

Förderung

  • Scientific Research Project of Shanxi Provincial Health Commission

Zitieren

APA

Yuan, X., Xue, R., & Cao, X. (2023). Network meta-analysis of treatments for perineal extramammary paget’s disease: Focusing on performance of recurrence prevention. PLOS ONE. https://doi.org/10.1371/journal.pone.0294152

Vancouver

Yuan X, Xue R, Cao X. Network meta-analysis of treatments for perineal extramammary paget’s disease: Focusing on performance of recurrence prevention. PLOS ONE. 2023. doi:10.1371/journal.pone.0294152

BibTeX
@article{Yuan2023,
  author = {Yuan, Xiaobin and Xue, Ruizhi and Cao, Xiaoming},
  title = {Network meta-analysis of treatments for perineal extramammary paget’s disease: Focusing on performance of recurrence prevention},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0294152}
}
Kostenlos starten →